Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1041-1056. doi: 10.1016/j.bbalip.2018.06.002. Epub 2018 Jun 6.

Abstract

The hepatitis C virus (HCV) life cycle is tightly linked to the host cell lipid metabolism with the endoplasmic reticulum-derived membranous web harboring viral RNA replication complexes and lipid droplets as virion assembly sites. To investigate HCV-induced changes in the lipid composition, we performed quantitative shotgun lipidomic studies of whole cell extracts and subcellular compartments. Our results indicate that HCV infection reduces the ratio of neutral to membrane lipids. While the amount of neutral lipids and lipid droplet morphology were unchanged, membrane lipids, especially cholesterol and phospholipids, accumulated in the microsomal fraction in HCV-infected cells. In addition, HCV-infected cells had a higher relative abundance of phosphatidylcholines and triglycerides with longer fatty acyl chains and a strikingly increased utilization of C18 fatty acids, most prominently oleic acid (FA [18:1]). Accordingly, depletion of fatty acid elongases and desaturases impaired HCV replication. Moreover, the analysis of free fatty acids revealed increased levels of polyunsaturated fatty acids (PUFAs) caused by HCV infection. Interestingly, inhibition of the PUFA synthesis pathway via knockdown of the rate-limiting Δ6-desaturase enzyme or by treatment with a high dose of a small-molecule inhibitor impaired viral progeny production, indicating that elevated PUFAs are needed for virion morphogenesis. In contrast, pretreatment with low inhibitor concentrations promoted HCV translation and/or early RNA replication. Taken together our results demonstrate the complex remodeling of the host cell lipid metabolism induced by HCV to enhance both virus replication and progeny production.

Keywords: Fatty acid elongases and desaturases; Hepatitis C virus; Lipid droplets; Lipidomics; Membranous web; Virus replication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyltransferases / antagonists & inhibitors
  • Acetyltransferases / genetics
  • Acetyltransferases / metabolism
  • Cell Line, Tumor
  • Cholesterol / metabolism
  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum / virology
  • Fatty Acid Desaturases / antagonists & inhibitors
  • Fatty Acid Desaturases / genetics
  • Fatty Acid Desaturases / metabolism
  • Fatty Acid Elongases
  • Fatty Acids, Unsaturated / metabolism
  • Gene Expression Regulation
  • Hepacivirus / growth & development
  • Hepacivirus / metabolism*
  • Hepatocytes / chemistry
  • Hepatocytes / metabolism*
  • Hepatocytes / virology
  • Host-Pathogen Interactions*
  • Humans
  • Lipid Droplets / metabolism
  • Lipid Droplets / virology
  • Lipid Metabolism / genetics*
  • Metabolome*
  • Microsomes / metabolism
  • Microsomes / virology
  • Oleic Acid / metabolism
  • Phosphatidylcholines / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • RNA, Viral / biosynthesis
  • RNA, Viral / genetics
  • Triglycerides / metabolism
  • Virion / growth & development
  • Virion / metabolism*
  • Virus Assembly / physiology
  • Virus Replication / physiology*

Substances

  • Fatty Acids, Unsaturated
  • Phosphatidylcholines
  • RNA, Small Interfering
  • RNA, Viral
  • Triglycerides
  • Oleic Acid
  • Cholesterol
  • Fatty Acid Desaturases
  • Acetyltransferases
  • Fatty Acid Elongases